These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues. Charalambous M, Menheniott TR, Bennett WR, Kelly SM, Dell G, Dandolo L, Ward A. Dev Biol; 2004 Jul 15; 271(2):488-97. PubMed ID: 15223349 [Abstract] [Full Text] [Related]
7. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Wada M, Seeger RC, Mizoguchi H, Koeffler HP. Cancer Res; 1995 Aug 01; 55(15):3386-8. PubMed ID: 7614476 [Abstract] [Full Text] [Related]
8. Igf2r improves the survival and transmission ratio of Igf2 transgenic mice. Pravtcheva DD, Wise TL. Mol Reprod Dev; 2008 Nov 01; 75(11):1678-87. PubMed ID: 18361416 [Abstract] [Full Text] [Related]
9. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome. Squire JA, Li M, Perlikowski S, Fei YL, Bayani J, Zhang ZM, Weksberg R. Genomics; 2000 May 01; 65(3):234-42. PubMed ID: 10857747 [Abstract] [Full Text] [Related]
11. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Vernucci M, Cerrato F, Besnard N, Casola S, Pedone PV, Bruni CB, Riccio A. Oncogene; 2000 Dec 14; 19(54):6376-85. PubMed ID: 11175353 [Abstract] [Full Text] [Related]
12. Role of H19 3' sequences in controlling H19 and Igf2 imprinting and expression. Verona RI, Bartolomei MS. Genomics; 2004 Jul 14; 84(1):59-68. PubMed ID: 15203204 [Abstract] [Full Text] [Related]
13. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Reeve AE. Med Pediatr Oncol; 1996 Nov 14; 27(5):470-5. PubMed ID: 8827076 [Abstract] [Full Text] [Related]
14. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR. Genomics; 2000 Mar 01; 64(2):132-43. PubMed ID: 10729220 [Abstract] [Full Text] [Related]
15. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A. J Urol; 1997 May 01; 157(5):1977-9. PubMed ID: 9112575 [Abstract] [Full Text] [Related]
16. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas. Rainho CA, Pontes A, Rogatto SR. Gynecol Oncol; 1999 Sep 01; 74(3):375-80. PubMed ID: 10479496 [Abstract] [Full Text] [Related]
17. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Bell AC, Felsenfeld G. Nature; 2000 May 25; 405(6785):482-5. PubMed ID: 10839546 [Abstract] [Full Text] [Related]
18. Enhancer competition between H19 and Igf2 does not mediate their imprinting. Schmidt JV, Levorse JM, Tilghman SM. Proc Natl Acad Sci U S A; 1999 Aug 17; 96(17):9733-8. PubMed ID: 10449763 [Abstract] [Full Text] [Related]
19. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts. Kiess W, Paquette J, Koepf G, Wolf E, Deal C. Biochem Biophys Res Commun; 1999 Feb 16; 255(2):226-30. PubMed ID: 10049690 [Abstract] [Full Text] [Related]
20. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, Hu JF, Behr B, Giudice L, Hoffman AR. Mol Hum Reprod; 2005 Sep 16; 11(9):631-40. PubMed ID: 16219628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]